This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
RLI Benefits From Premium Growth, Rising Costs a Concern
by Zacks Equity Research
RLI continues to gain from consistent premium growth, better investment results and a strong capital position. However, exposure to cat loss and rising expenses are spoilers.
Brown & Brown (BRO) Unit Buyout to Enrich Service Portfolio
by Zacks Equity Research
Brown & Brown (BRO) arm buys Rodman Insurance, which is anticipated to add substance to the company's service portfolio via a comprehensive suite of P&C insurance products and services.
Assurant (AIZ) Rewards Shareholders With 7% Dividend Hike
by Zacks Equity Research
Assurant (AIZ) instills investors' confidence in the stock with a dividend increase of 7%.
The Zacks Analyst Blog Highlights: ExxonMobil, Occidental Petroleum, General Motors, MetLife and Digital Realty Trust
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ExxonMobil, Occidental Petroleum, General Motors, MetLife and Digital Realty Trust
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Research Reports for ExxonMobil, Occidental Petroleum & General Motors
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Occidental Petroleum (OXY) and General Motors (GM).
Company News For Nov 2, 2018
by Zacks Equity Research
Companies In The News Are: W,MSI,MET,PGTI
MetLife (MET) Q3 Earnings Top Estimates on Volume Growth
by Zacks Equity Research
MetLife (MET) Q3 encourages with volume growth, favorable underwriting, expense management and an improved investment income.
MetLife (MET) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 10.40% and 1.65%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Insurers Set to Report Q3 Earnings on Nov 1: CI, MET, LNC, Y
by Zacks Equity Research
Insurers' third-quarter performance is likely to be supported by a favorable operating environment, although catastrophe loss can be a drag.
What's in Store for MetLife (MET) Stock in Q3 Earnings?
by Zacks Equity Research
MetLife's (MET) Q3 earnings should gain from growth revenues partly offset by higher expenses.
MetLife (MET) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: ArcBest, American Axle, MetLife and Prudential
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, American Axle, MetLife and Prudential
Unlock the Value of Your Portfolio With 4 Low P/CF Stocks
by Zacks Equity Research
When it comes to the investment market, experts consider value style as one of the most effective approaches.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier Advanced, ON Semiconductor and Huntsman
by Zacks Equity Research
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier Advanced, ON Semiconductor and Huntsman
Boost Your Portfolio With These 5 Low P/B Ratio Stocks
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
Zacks.com featured highlights include: ArcBest, ON, MetLife and Stifel
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, ON, MetLife and Stifel
Add These 4 Low P/CF Stocks to Create a Value-Based Portfolio
by Zacks Equity Research
Analysts caution that a company's earnings are subject to accounting estimates and management manipulation. On the other hand, cash flow is reliable.
Market Rallies Despite Trade Worries: 5 Blue-Chip Picks
by Nalak Das
The current momentum in stock markets can primarily attributed to large-cap blue-chip stocks as investors shrugged off trade war jitters.
Is MetLife (MET) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Caterpillar, International Paper, MetLife and Broadcom
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Caterpillar, International Paper, MetLife and Broadcom
Lehman Brothers' Collapse: Did the Markets Learn Any Lesson?
by Nilanjan Banerjee
Investors who didn't follow the crowd and held on to stocks after the Lehman meltdown pocketed massive gains.
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier, ON and PCM
by Zacks Equity Research
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier, ON and PCM
5 Low Price-to-Book Value Stocks to Buy in September
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.